Tag Archives: BCRX

Hot Low Price Stocks To Watch Right Now

Leave a reply

Activision Blizzard (NASDAQ:ATVI), Electronic Arts (NASDAQ:EA), and Take Two Interactive (NASDAQ:TTWO) have each launched professional esports leagues this year, while advertising and sponsorships are expected to make up three-quarters of the industry’s nearly $1 billion of revenue. And the recent announcement that Nielsen Holdings (NYSE:NLSN) will apply its TV rating expertise to Activision’s esport events could be the catalyst that unleashes a floodgate of media buying.

In this segment from Industry Focus: Consumer Goods, the cast discusses these latest developments and more.

A full transcript follows the video.

This video was recorded on May 22, 2018.

Vincent Shen: Investors are pretty fortunate with video games in that there are quite a few publicly traded companies targeting the esports opportunity. They also happen to be some of the leading names in the industry.

A lot of our listeners have probably heard of Activision Blizzard, ticker ATVI; Electronic Arts, ticker EA; Take-Two Interactive, ticker TTWO. Across the board, we’re seeing esports come up more and more in these companies’ press releases and their earnings calls. I’m going to share a few quotes from management teams. It’s not like I had to go digging to find these examples — these are all from the most recent quarterly investor calls.

Hot Low Price Stocks To Watch Right Now: TGC Industries Inc.(TGE)

TGC Industries, Inc. provides geophysical services for clients in the oil and gas business in the United States and Canada. It conducts three-D surveys and seismic data acquisition services primarily to onshore oil and natural gas exploration and development companies for use in the onshore drilling and production of oil and natural gas. The company also owns a data bank that contains gravity data and magnetic data from oil and natural gas producing areas located in the United States. It operates 8 seismic crews in the lower 48 states in the United States, as well as 2 crews in Canada. The company was formerly known as Tidelands Geophysical Co., Inc. and changed its name to TGC Industries, Inc. in July 1986. TGC Industries, Inc. was founded in 1967 and is headquartered in Plano, Texas.

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Tallgrass Energy (NYSE:TGE) currently boasts the biggest payout in this group at 8.9%. The pipeline company can easily support that big dividend since it generates very stable cash flow backed by long-term contracts, has a conservative payout ratio, and has a solid balance sheet. However, what makes Tallgrass Energy even more enticing is its growth prospects. The company currently has three large-scale oil infrastructure investments under development, which could fuel significant growth in the coming years. As such, investors are getting paid very well to wait for that upside to materialize.

  • [By Stephan Byrd]

    The firm also recently announced a quarterly dividend, which was paid on Thursday, February 14th. Stockholders of record on Thursday, January 31st were given a $0.52 dividend. The ex-dividend date was Wednesday, January 30th. This is an increase from Tallgrass Energy’s previous quarterly dividend of $0.51. This represents a $2.08 dividend on an annualized basis and a dividend yield of 9.11%. Tallgrass Energy’s dividend payout ratio is currently 163.78%.

    ILLEGAL ACTIVITY NOTICE: “Ffcm LLC Takes $38,000 Position in Tallgrass Energy LP (TGE)” was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at www.tickerreport.com/banking-finance/4195528/ffcm-llc-takes-38000-position-in-tallgrass-energy-lp-tge.html.

    About Tallgrass Energy

Hot Low Price Stocks To Watch Right Now: Nymox Pharmaceutical Corporation(NYMX)

Nymox Pharmaceutical Corporation, incorporated on May 30, 1995, is a biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the aging population segment. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also has a range of patent portfolio covering its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the United States and global patent rights for the use of statin drugs for the treatment and prevention of Alzheimer’s disease. The Company’s subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex, Inc. conducts research and development, and manufacturing of NicAlert and TobacAlert.

The Company’s NicAlert and TobacAlert are the test strips, which determine whether a person is using tobacco products (NicAlert) or has been exposed to second-hand smoke (TobacAlert). Both NicAlert and TobacAlert provide a read-out of levels of cotinine, a by-product of the body’s breakdown of nicotine and regarded as the indicator of tobacco exposure for smokers and non-smokers. The technology can be used with saliva, as well as urine samples in order to detect tobacco product use. The Company’s AlzheimAlert is a urine assay that can aid physicians in the diagnosis of Alzheimer’s disease. The Company has developed a kit version of the AlzheimAlert assay for sale in Europe. The kit allows clinical reference laboratories to perform the AlzheimAlert assay on site with urine samples sent directly to the laboratory.

The Company is developing treatments for BPH. The Company’s lead candidate NX-1207 completed a multi-center, double-blind, placebo-controlled Phase II trial. The ! Company is in the process of further data analysis and assessments of the two studies. The Company is also developing NX-1207 as a focal treatment for certain types of cancer. The Company initiated a Phase II clinical trial in the United States. The Company enrolled approximately 147 patients at over 28 clinical centers across the United States to evaluate its NX-1207 drug for the treatment of low-grade localized prostate cancer.

The Company competes with LabCorp, Quest Diagnostics, OraSure Technologies Inc., Abraxis LLC, Roche Diagnostics, Abbott, Siemens Medical Solutions, Mossman & Associates Ltd, GFC Diagnostics Ltd., Lilly and GE Healthcare.

Advisors’ Opinion:

  • [By Logan Wallace]

    IDEXX Laboratories (NASDAQ: IDXX) and Nymox Pharmaceutical (NASDAQ:NYMX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership.

Hot Low Price Stocks To Watch Right Now: Scorpio Tankers Inc.(STNG)

Scorpio Tankers Inc. provides marine transportation of crude oil and refined petroleum products worldwide. As of April 26, 2011, it owned one LR2 tanker, four LR1 tankers, four Handymax tankers, and one post-Panamax tanker, as well as chartered one LR1 and four Handymax product tankers. The company was founded in 2009 and is based in Monaco, Monaco.

Advisors’ Opinion:

  • [By Stephan Byrd]

    WARNING: “Boston Partners Decreases Holdings in Scorpio Tankers Inc. (STNG)” was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at www.tickerreport.com/banking-finance/4180102/boston-partners-decreases-holdings-in-scorpio-tankers-inc-stng.html.

  • [By Motley Fool Transcribers]

    Scorpio Tankers Inc (NYSE:STNG)Q42018 Earnings Conference CallFeb. 14, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Scorpio Tankers Inc. (NYSE:STNG)’s share price reached a new 52-week low during trading on Friday . The company traded as low as $1.78 and last traded at $1.78, with a volume of 151745 shares traded. The stock had previously closed at $1.80.

  • [By Joseph Griffin]

    Scorpio Tankers Inc. (NYSE:STNG) gapped down before the market opened on Thursday . The stock had previously closed at $1.75, but opened at $1.82. Scorpio Tankers shares last traded at $1.81, with a volume of 169888 shares traded.

Hot Low Price Stocks To Watch Right Now: Cache Inc.(CACH)

Cache, Inc., together with its subsidiaries, operates as a mall and Web based specialty retailer of women?s lifestyle sportswear and dresses in the United States. It offers eveningwear; casual and daytime sportswear, including tops, bottoms, and dresses; and accessories, such as jewelry, belts, and handbags under the Cache brand name. The company also provides its products online through its Web site, cache.com. As of March 22, 2012, it operated 267 stores in 43 states, Puerto Rico, and the U.S. Virgin Islands. Cache, Inc. was founded in 1975 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Max Byerly]

    Cache (OTCMKTS: CACH) and New York & Company, Inc. (NYSE:NWY) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

  • [By Shane Hupp]

    CacheCoin (CACH) is a proof-of-work (PoW) coin that uses the Scrypt hashing algorithm. It was first traded on January 5th, 2014. CacheCoin’s total supply is 4,195,132 coins. CacheCoin’s official Twitter account is @CACHeCoin. The Reddit community for CacheCoin is /r/cachecoin and the currency’s Github account can be viewed here. The official website for CacheCoin is www.cachecoin.cc.

Hot Low Price Stocks To Watch Right Now: Evertec, Inc.(EVTC)

EVERTEC, Inc., formerly Carib Latam Holdings, Inc., incorporated on April 13, 2012, is a full-service transaction processing company. The Company provides a range of merchant acquiring, payment processing and business process management services across approximately 20 countries. The Company operates through three segments: Merchant Acquiring, Payment Processing and Business Solutions. The Company owns and operates the ATH network, an automated teller machine (ATM) and personal identification number (PIN) debit network in Latin America. In addition, the Company provides a range of services for core bank processing, cash processing and technology outsourcing in the regions it serves. The Company serves a diversified customer base of financial institutions, merchants, corporations and government agencies with solutions that enable them to issue, process and accept transactions securely. It manages a system of electronic payment networks that process approximately two billion transactions annually. The Company’s suite of services spans the entire transaction processing value chain and includes a range of front-end customer-facing solutions, such as the electronic capture and authorization of transactions at the point-of-sale (POS), as well as back-end support services, such as the clearing and settlement of transactions and account reconciliation for card issuers.

Merchant Acquiring

The Company’s merchant acquiring business provides services to merchants that allow them to accept electronic methods of payment, such as debit, credit, prepaid and electronic benefit transfer (EBT) cards, carrying the ATH, Visa, MasterCard, Discover and American Express brands. Its suite of merchant acquiring services includes the underwriting of each merchant’s contract, the deployment and rental of POS devices and other equipment necessary to capture merchant transactions, the processing of transactions at the POS, the settlement of funds with the participating financial institution, detailed sale! s reports and customer support.

Payment Processing

The Company is a card processor and network services provider in the Caribbean. It provides a suite of payment processing products and services to blue chip regional and global corporate customers, government agencies and financial institutions across Latin American and the Caribbean. These services provide the infrastructure technology necessary to facilitate the processing and routing of payments across the transaction processing value chain. At the POS, it sells transaction processing technology solutions to other merchant acquirers to enable them to service its own merchant customers. It also offers terminal driving solutions to merchants, merchant acquirers (including its merchant acquiring business) and financial institutions, which provide the technology to operate, manage and monitor POS terminals and ATMs. It also rents POS devices to financial institution customers who seek to deploy them across their own businesses.

The ATH network connects the merchant or merchant acquirer to the card issuer and enables transactions to be routed or switched across the transaction processing value chain. The ATH network offers the technology, communications standards, rules and procedures, security and encryption, funds settlement and common branding that allow consumers, merchants, merchant acquirers, ATMs, card issuer processors and card issuers to conduct commerce across a range of channels. To enable financial institutions, governments and other businesses to issue and operate a range of payment products and services, it offers a range of card processing and other payment technology services, such as Internet and mobile banking software services, bill payment systems and EBT solutions. Financial institutions and certain retailers outsource to the Company certain card processing services, such as card issuance, processing card applications, cardholder account maintenance, transaction authorization and posting, fraud a! nd risk m! anagement services, and settlement. Its payment products include electronic check processing, automated clearing house (ACH), lockbox, online, interactive voice response and Web-based payments through personalized Websites, among others. Its EBT application allows certain agencies to deliver government benefits to participants through a magnetic card system and serves over 7,80,000 active participants.

Business Solutions

The Company provides its financial institution, corporate and government customers with a suite of business process management solutions. These solutions include core bank processing, network hosting and management, information technology (IT) consulting services, business process outsourcing, item and cash processing, and fulfillment.

The Company competes with Vantiv, Inc., First Data Corporation, Global Payments Inc., Elavon, Inc., Sage Payment Solutions, Fidelity National Information Services, Inc., Fiserv, Inc., Total System Services, Inc., MasterCard, Visa, American Express and Discover.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Evertec Inc (NYSE:EVTC) have been assigned an average rating of “Hold” from the twelve analysts that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation, three have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $23.20.

  • [By ]

    3. Evertec (NYSE: EVTC)
    A Puerto Rico-based payment processor that has soared by over 75% this year but maintains a forward P/E around 14, placing the shares firmly in the value category.

  • [By Matthew Cochrane]

    Which individual stocks in the ETF’s portfolio have done the heaviest lifting? This year, so far, that honor belongs to First Data Corp. (NYSE:FDC), Evertec Inc. (NYSE:EVTC), and Square Inc. (NYSE:SQ). That’s after screening for companies in the fund’s portfolio that trade on a domestic stock exchange and have a market cap greater than $1 billion. Let’s take a closer look at all three to see why these companies’ stocks have appreciated so far this year.

  • [By Shane Hupp]

    Equities research analysts at Raymond James initiated coverage on shares of Evertec (NYSE:EVTC) in a report released on Friday, MarketBeat reports. The firm set a “market perform” rating on the business services provider’s stock.

Hot Low Price Stocks To Watch Right Now: BioCryst Pharmaceuticals Inc.(BCRX)

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer to develop new therapeutic candidates. The company has three novel late-stage compounds in development, which include Peramivir, a neuraminidase inhibitor for the potential treatment of influenza; BCX4208, a purine nucleoside phosphorylase (PNP) inhibitor for gout; and Forodesine, a PNP inhibitor for cutaneous T-cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority within the United States Department of Health and Human Services. Forodesine has been granted orphan drug status by the FDA for thr ee indications, which include T-cell non-Hodgkin?s lymphoma, including CTCL; CLL and related leukemias, including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for treatment of B-ALL. The FDA has also granted fast track status to the development of forodesine for the treatment of relapsed or refractory T-cell leukemia, and special protocol assessment from the FDA for forodesine to conduct a pivotal clinical trial in CTCL with an oral formulation. The company announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone. BioCryst Pharmaceuticals utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)Q42018 Earnings Conference CallMarch 04, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) rose over 21% last month, according to data provided by S&P Global Market Intelligence. In the beginning of the month, the company announced the successful sale of 10.4 million shares that raised around $57.5 million in gross proceeds.

Hot Medical Stocks To Watch Right Now

Leave a reply

CryoLife, Inc. (NYSE:CRY) manufactures, processes, and distributes medical devices and implantable living tissues used in cardiac and vascular surgical procedures. From mid-April until early October, the stock has done well, rising over 60%. Since then however, the share price dropped 20% due to a disappointing Q3 earnings report and lowered full-year guidance, resulting at least partially from the negative impact of recent hurricanes. The share price further plummeted after the company announced a $225 million acquisition of JOTEC, German-based, privately-held developer of technologically differentiated endovascular stent grafts.

CRY data by YCharts

Hot Medical Stocks To Watch Right Now: Patriot National Bancorp Inc.(PNBK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Patriot National Bancorp (NASDAQ: PNBK) and Community Bank, N.A. (NYSE:CBU) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations and profitability.

Hot Medical Stocks To Watch Right Now: Rada Electronics Industries Limited(RADA)

Advisors’ Opinion:

  • [By Logan Wallace]

    TESSCO Technologies (NASDAQ: TESS) and RADA Electronic Industries (NASDAQ:RADA) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, risk and earnings.

Hot Medical Stocks To Watch Right Now: iShares PHLX SOX Semiconductor Sector Index Fund(SOXX)

Advisors’ Opinion:

  • [By Jim Crumly]

    Semiconductor stocks rose on news of a deal with China to grant a reprieve to ZTE, with theiShares PHLX Semiconductor ETF (NASDAQ:SOXX) moving up 1.2%.Energy shares gained, too; the SPDR S&P Oil & Gas Exploration & Production ETF (NYSEMKT:XOP) closed up 1.3%.

  • [By Joseph Griffin]

    Essex Financial Services Inc. bought a new position in iShares PHLX Semiconductor ETF (NASDAQ:SOXX) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,765 shares of the exchange traded fund’s stock, valued at approximately $318,000.

Hot Medical Stocks To Watch Right Now: BioCryst Pharmaceuticals Inc.(BCRX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Stocks To Watch For 2018

Leave a reply

Blockchain stocks appear to be the next big thing (or bubble) to trade with pure play blockchain stock Riot Blockchain Inc (NASDAQ: RIOT) closing up 47.59% on Friday and rising by a double digit percentage in premarket trading this morning while small cap Marathon Patent Group Inc (NASDAQ: MARA) surged 171.69% and is rising as much as 90% in premarket trading. Blockchains are decentralized digital ledgers that record and enable secure peer-to-peer transactions without third party intermediaries. They also form the basis for Bitcoin.

For Riot Blockchain, there appears to be no big company specific news to explain why investors/traders are now salivating beyond a Tuesday announcement of the appointment of Frank M. Bishop to the Company Advisory Board. Mr. Bishop served as a member of the senior management team that built INVESCO into one of the largest publicly traded global investment management companies.

Top Stocks To Watch For 2018: LaSalle Hotel Properties(LHO)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on LaSalle Hotel Properties (LHO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Boenning Scattergood reaffirmed their hold rating on shares of LaSalle Hotel Properties (NYSE:LHO) in a research report report published on Friday.

  • [By Paul Ausick]

    LaSalle Hotel Properties (NYSE: LHO) fell about 14% Wednesday to post a new 52-week low of $24.00 after closing at $28.25 on Tuesday. The 52-week high is $31.75. Volume of about 12.2 million was more than 10 times the daily average. The company’s results were hit hard by Hurricane Irma.

  • [By Joseph Griffin]

    LaSalle Hotel Properties (NYSE:LHO) issued an update on its second quarter earnings guidance on Thursday morning. The company provided EPS guidance of $0.74-0.77 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.70. LaSalle Hotel Properties also updated its FY18 guidance to $2.16-2.19 EPS.

Top Stocks To Watch For 2018: Starwood Hotels & Resorts Worldwide, Inc.(HOT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Hydro Protocol (CURRENCY:HOT) traded up 15.6% against the US dollar during the 24-hour period ending at 19:00 PM ET on May 5th. During the last week, Hydro Protocol has traded up 93.2% against the US dollar. One Hydro Protocol token can currently be purchased for approximately $0.10 or 0.00001044 BTC on major exchanges including BigONE, DDEX and OKEx. Hydro Protocol has a total market cap of $72.13 million and approximately $1.91 million worth of Hydro Protocol was traded on exchanges in the last day.

Top Stocks To Watch For 2018: NBT Bancorp Inc.(NBTB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on NBT Bancorp (NBTB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    NBT Bancorp (NASDAQ:NBTB) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

Top Stocks To Watch For 2018: Celanese Corporation(CE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Celanese (NYSE: CE) and Sealed Air (NYSE:SEE) are both basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

  • [By ]

    Eli Lilly announced in October it was conducting a strategic review for the unit.  Elanco on Monday said it has appointed Christopher Jensen, who was most recently with Celanese Corp. (CE) , as chief financial officer.

  • [By Ethan Ryder]

    Celanese (NYSE:CE)‘s stock had its “outperform” rating reiterated by Cowen in a report issued on Friday. They presently have a $125.00 price objective on the basic materials company’s stock, up from their previous price objective of $120.00. Cowen’s price objective would suggest a potential upside of 15.06% from the company’s previous close.

Top Stocks To Watch For 2018: Collegium Pharmaceutical, Inc.(COLL)

Advisors’ Opinion:

  • [By Todd Campbell]

    Depomed is in the middle of a restructuring of its business that includes out-licensing its lead drug, Nucynta. In December, Collegium (NASDAQ:COLL) cut a licensing deal for Nucynta that guarantees Depomed $135 million in annual royalties, paid quarterly in arrears, for four years. If sales exceed$233 million per year, then Collegium Pharmaceutical will also pay Depomed a double-digit royalty on top of the minimum license fee. After four years, Depomed will receive double-digit royalties on all net Nucynta sales.

  • [By Logan Wallace]

    Collegium Pharmaceutical (NASDAQ:COLL) – Piper Jaffray lowered their FY2021 EPS estimates for shares of Collegium Pharmaceutical in a note issued to investors on Wednesday, May 9th. Piper Jaffray analyst D. Amsellem now forecasts that the specialty pharmaceutical company will post earnings per share of $2.06 for the year, down from their previous forecast of $2.32. Piper Jaffray has a “Buy” rating and a $33.00 price target on the stock.

Top Stocks To Watch For 2018: BioCryst Pharmaceuticals Inc.(BCRX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

best stock buys

Leave a reply

James and Carrie Finan have been house-hunting in the Seattle area for four months in a seemingly futile race against time: Theyre living in a room in James mothers house and their first child is due in September.

Theyve seen about 40 starterhouses that match their criteria$350,000 or less, three bedrooms, about 1,200 square feet — and made four offers ranging from $32,000 to $82,000 above asking price. Theyve lost out each time.

Every time we hear were not getting it, my heart kind of sinks, James, 29, says. Its been insane.

A big reason the Finans are struggling is the regulatory morass faced by builders like Mike Walsh. On a parcel in Sammamish, Wash., a Seattle suburb, he wouldlike to build 36 relatively affordable houses. But since zoning changes in recent years permit just 25, hell have to sell each at $1.2 million to make the project profitable.

best stock buys: Myriad Genetics, Inc.(MYGN)

Advisors’ Opinion:

  • [By Cory Renauer]

    Shares of Myriad Genetics, Inc. (NASDAQ:MYGN), a DNA diagnostics specialist, dropped 61.4% last year, according todata from S&P Global Market Intelligence.Efforts to offset hereditary cancer-testing segment losses just weren’t successful enough to keep profits, and the stock, from sliding last year.

best stock buys: PowerShares S&P SmallCap Information Technology Portfolio(PSCT)

Advisors’ Opinion:

  • [By ]

    On this chart, I plotted the year-to-date performance of the Nasdaq Composite index against two exchange-traded funds (ETFs) — one is an ETF that tracks the small-cap Russell 2000 index, and the other is PowerShares S&P SmallCap Information Technology Portfolio ETF (Nasdaq: PSCT), which serves as a proxy for the types of small-cap tech stocks that are a focus of my premium newsletter, Game-Changing Stocks.

  • [By ]

    Overall, our Game-Changing Stocks portfolio has had a good run this year. Our closed positions for 2017 have, on average, returned 28.5% — a much stronger result than what we’ve seen from the Russell 2000 index or from the PowerShares S&P Small Cap Information Technology Portfolio ETF (Nasdaq: PSCT), which returned 13% and 11% year-to-date, respectively. It’s not a fair comparison, of course, because our closed positions all have different time frames, but it does stress the strong promise of game-changing stocks.

best stock buys: OneBeacon Insurance Group, Ltd.(OB)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

best stock buys: BioCryst Pharmaceuticals Inc.(BCRX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By Sean Williams]

    Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX), a biotech company that develops small-molecule drugs to block enzymes involved in disease proliferation, surged as much as 12% today after a report was issued that a highly pathogenic H5N1 bird flu was found in the northern part of Malaysia.

  • [By Monica Gerson]

    BioCryst Pharmaceuticals (NASDAQ: BCRX) shares gained 5.98% to $6.91 in the pre-market session after the company has been awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease.

best stock buys: Lifetime Brands Inc.(LCUT)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Monday, cyclical consumer goods & services shares gained by 0.41 percent. Top gainers in the sector included Kandi Technologies Group Inc (NASDAQ: KNDI), Starwood Hotels & Resorts Worldwide Inc (NYSE: HOT), and Lifetime Brands Inc (NASDAQ: LCUT).

best stock buys: Paragon Offshore plc (PGNPQ)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Paragon Offshore’s (OTCPK:PGNPQ) former management’s audacious efforts to omit parts of the senior secured lenders by deeming them unimpaired and instead pay out the majority of the company’s cash to junior unsecured bondholders by presenting a set of entirely unrealistic business forecasts to the court. Fortunately, in case of Paragon Offshore, the bankruptcy judge recognized the framing and accordingly denied confirmation of the company’s plan of reorganization, effectively sending Paragon Offshore back to the drawing board. Consequently, management was ousted after the failure. I have covered the Paragon Offshore saga in a series of articles over the past few quarters, so interested investors might want to take a look at this highly fascinating and still evolving case study.

  • [By SEEKINGALPHA.COM]

    With even brand new rigs struggling to find work, the jig was soon up for owners of old equipment, like Paragon Offshore (OTCPK:PGNPQ), which is currently undergoing its second debt restructuring in less than three years of independent existence. Likewise, drillers with a fondness for aggressive use of debt were soon in trouble, most notably, former high-flier Seadrill (SDRL) and its little brother North Atlantic Drilling (NADL), which will no doubt file for restructuring within months. As a consequence of the crisis, the OSD industry now has a number of participants without a large debt burden, either new entrants like Borr Drilling, or established competitors that have had debt reduced in a restructuring, such as Ocean Rig (ORIG), to be followed within this year by others, almost certainly including each of SDRL, NADL, and Pacific Drilling (PACD).

Hot Undervalued Stocks To Watch Right Now

Leave a reply

LM Ericsson Telephone (ERIC)

Welcome. In this article I will give the dollar and cents reasons for how come ERIC looks like a relative bargain in today’s marketplace.

Story

In the trailing ten years ERIC has earned their market cap in free cash flow. This is a signal the company may be undervalued. If ERIC can repeat the performance and earn over $19B in the coming ten years. In a market where many companies are being valued at twice or three times as much free cash flow as they’ve generated over the trailing ten years, this factor alone makes ERIC a relative bargain.

Hot Undervalued Stocks To Watch Right Now: Boston Properties, Inc.(BXP)

Advisors’ Opinion:

  • [By Paul R. La Monica]

    The fund owned big U.S. real estate investment trusts Boston Properties (BXP) and Vornado (VNO), as well as Japan’s Sumitomo Realty, as of the end of last year. REITs are known for their big dividends.

  • [By Markus Aarnio]

    Owens Realty Mortgage’s competitors include American Assets Trust (AAT), Alexandria Real Estate Equities (ARE) and Boston Properties (BXP). American Assets Trust has seen five insider buy transactions and four insider sell transactions this year. American Assets Trust has a dividend yield of 2.78%. Alexandria Real Estate Equities has seen 14 insider sell transactions this year. Alexandria Real Estate Equities has a dividend yield of 4.10%. Boston Properties has seen one insider buy transaction and four insider sell transactions this year. Boston Properties has a dividend yield of 2.43%.

Hot Undervalued Stocks To Watch Right Now: Credicorp Ltd.(BAP)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Bank of Nova Scotia (The) (NYSE: BNS): Free Stock Analysis Report
     
    Banco Bilbao Viscaya Argentaria S.A. (NYSE: BBVA): Free Stock Analysis Report
     
    Credicorp Ltd. (NYSE: BAP): Free Stock Analysis Report
     
    Bank of N.T. Butterfield & Son Limited (The) (NTB): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.

Hot Undervalued Stocks To Watch Right Now: Cotiviti Holdings, Inc. (COTV)

Advisors’ Opinion:

  • [By Scott Rubin]

    Big gainers on the day included Intersil Corp (NASDAQ: ISIL), which jumped 20 percent on news of a buyout, and Medivation (NASDAQ: MDVN), which added 20 percent on a deal with Pfizer (NYSE: PFE) related to its cancer drug. Cotiviti Holdings Inc (NYSE: COTV) lost around 9 percent in the wake of a mid-day sell-off and Marathon Oil Corporation (NYSE: MRO) fell 7 percent in the wake of a management shakeup.

Hot Undervalued Stocks To Watch Right Now: BioCryst Pharmaceuticals Inc.(BCRX)

Advisors’ Opinion:

  • [By Sean Williams]

    Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX), a biotech company that develops small-molecule drugs to block enzymes involved in disease proliferation, surged as much as 12% today after a report was issued that a highly pathogenic H5N1 bird flu was found in the northern part of Malaysia.

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By Monica Gerson]

    BioCryst Pharmaceuticals (NASDAQ: BCRX) shares gained 5.98% to $6.91 in the pre-market session after the company has been awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease.

Hot Undervalued Stocks To Watch Right Now: Pound/Rand(PX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The last twelve months haven’t been kind to Praxair (PX) and Air Products & Chemicals (APD), but UBS analyst John Roberts and team argue that’s about to change, as they upgrade their shares to Buy from Neutral arguing that their earnings can withstand a slowing global economy:

    In our view, the two stocks are more alike than different. NTM P/Es are within ~0.5 pts of each other. Both stocks have declined ~20% from their historical highs the largest corrections in 20+ years aside from the financial crisis…

    Industrial gas stocks have normally grown through changes in FX, oil & China demand within normal historical ranges. And investor concerns around China forAir Products & Chemicals may still prove much bigger than reality. Nevertheless, the combination of FX & oil sector impacts on Praxair, and FX & China issues for Air Products & Chemicals, have been much larger than previously seen. With oil already down, the dollar already appreciated, & China concerns already heightened we believe forward basis would appear to carry only normal risks (& lower if FX & oil are mean-reverting, which some theories support).

    Normal high single digit EPS growth projected for both in 2017 vs 2016: Four large firms serve 70%+ of the global merchant gas market, and price normally contributes ~2% to growth. Customer older captive units being outsourced contributes another 2%. Secular drivers for oxygen include energy savings (i.e. O2 burns more efficiently than air), life sciences (healthcare & microbial processes) nitrogen secular drivers include increasing purity requirements (food freezing & semiconductors). Topline growth ~2x global GDP more normal, with EPS growth ~2x sales growth due to high fixed costs (key variable costs are inexpensive air & power).

    Financial crisis demand drop was only a few %, in line with global GDP drop Most chemicals volumes dropped 10%+ (some 40%